Showing results (251-260 of 264) with videos related to
Sort By:
Pageof 27
Frontiers in Oncology|October 5, 2020
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive TherapySophie R de Mol van Otterloo, John P Christodouleas, Erwin L A Blezer, et al.Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.European Urology|August 7, 2022
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)Ting Martin Ma, Fang-I Chu, Howard Sandler, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2021
Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional RegistrySophie R de Mol van Otterloo, John P Christodouleas, Erwin L A Blezer, et al.The New England Journal of Medicine|October 29, 2015
DNA-Repair Defects and Olaparib in Metastatic Prostate CancerJoaquin Mateo, Suzanne Carreira, Shahneen Sandhu, et al.The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.JNCI Cancer Spectrum|October 20, 2023
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer typesElnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, et al.British Journal of Cancer|January 5, 2018
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predispositionChristos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, et al.European Urology|February 4, 2014
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyElizabeth K Bancroft, Elizabeth C Page, Elena Castro, et al.Pageof 27